Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

Launched by ALCON RESEARCH · Aug 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the long-term safety and effectiveness of special lenses called AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lenses (IOLs). These lenses are used to improve vision in people who have had cataract surgery and may have difficulty seeing clearly due to conditions like aphakia (missing the natural lens) or presbyopia (difficulty focusing on close objects). The trial aims to gather information about how well these lenses work in everyday life over a period of 3 to 5 years.

To participate in this study, you need to be at least 22 years old and have had either the AcrySof IQ Vivity or Vivity Toric lenses implanted in both eyes for 3 to 5 years. You'll also need to be able to understand and sign a consent form to join the study. Unfortunately, if you've had certain types of eye surgery after receiving these lenses, or if you are pregnant or nursing, you won't be eligible to participate. If you join, you’ll help researchers learn more about these lenses and how they can improve the quality of life for people with vision challenges.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • 22 years old or older at Visit 1.
• • Able to understand and sign an approved informed consent form.
• • Implantation of AcrySof IQ Vivity and/or Vivity Toric IOL models in both eyes for 3 to 5 years prior to enrollment.
• • Documented medical history and required pre-operative baseline information available for retrospective data collection.
• • Other protocol-specified inclusion criteria may apply.
• Key Exclusion Criteria:
• • Corneal refractive surgery after AcrySof Vivity or AcrySof Vivity Toric IOL implantation.
• • Pregnant or nursing at the time of enrollment.
• • Childbirth after IOL implantation.
• • Other protocol-specified exclusion criteria may apply.